| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Model |





¶
¶




¶
From the Department of Psychiatry and Neuropsychology,* Division of Cellular Neuroscience, University of Maastricht, Maastricht, The Netherlands; the Department of Anatomy,
Neuroembryonic Research Laboratory, University of Rostock, Rostock, Germany; the European Graduate School of Neuroscience,
EURON, Maastricht, The Netherlands; the Department of Anatomy and Cell Biology,
RWTH Aachen University, Aachen, Germany; the Department of Psychiatry,¶ Division of Neurobiology, University of Saarland Medical Center, Homburg/Saar, Germany; Aventis Pharma S.A.,|| Neurodegenerative Group and Functional Genomics, Centre de Recherche de Paris, Vitry sur Seine, France; Institut für Chemie/Biochemie,** Freie Universität Berlin, Berlin, Germany; and the Department of Neuropathology,
Institute of Psychiatry, KCL, London, United Kingdom
According to the "amyloid hypothesis of Alzheimers disease," ß-amyloid is the primary driving force in Alzheimers disease pathogenesis. Despite the development of many transgenic mouse lines developing abundant ß-amyloid-containing plaques in the brain, the actual link between amyloid plaques and neuron loss has not been clearly established, as reports on neuron loss in these models have remained controversial. We investigated transgenic mice expressing human mutant amyloid precursor protein APP751 (KM670/671NL and V717I) and human mutant presenilin-1 (PS-1 M146L). Stereologic and image analyses revealed substantial age-related neuron loss in the hippocampal pyramidal cell layer of APP/PS-1 double-transgenic mice. The loss of neurons was observed at sites of Aß aggregation and surrounding astrocytes but, most importantly, was also clearly observed in areas of the parenchyma distant from plaques. These findings point to the potential involvement of more than one mechanism in hippocampal neuron loss in this APP/PS-1 double-transgenic mouse model of Alzheimers disease.
This article has been cited by other articles:
![]() |
J. Wu, Md. R. Basha, B. Brock, D. P. Cox, F. Cardozo-Pelaez, C. A. McPherson, J. Harry, D. C. Rice, B. Maloney, D. Chen, et al. Alzheimer's Disease (AD)-Like Pathology in Aged Monkeys after Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD J. Neurosci., January 2, 2008; 28(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. He, Z. Zhong, K. Lindholm, L. Berning, W. Lee, C. Lemere, M. Staufenbiel, R. Li, and Y. Shen Deletion of tumor necrosis factor death receptor inhibits amyloid {beta} generation and prevents learning and memory deficits in Alzheimer's mice J. Cell Biol., August 27, 2007; 178(5): 829 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Capetillo-Zarate, M. Staufenbiel, D. Abramowski, C. Haass, A. Escher, C. Stadelmann, H. Yamaguchi, O. D. Wiestler, and D. R. Thal Selective vulnerability of different types of commissural neurons for amyloid {beta}-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology Brain, November 1, 2006; 129(11): 2992 - 3005. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oakley, S. L. Cole, S. Logan, E. Maus, P. Shao, J. Craft, A. Guillozet-Bongaarts, M. Ohno, J. Disterhoft, L. Van Eldik, et al. Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation J. Neurosci., October 4, 2006; 26(40): 10129 - 10140. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Thal, E. Capetillo-Zarate, K. Del Tredici, and H. Braak The Development of Amyloid beta Protein Deposits in the Aged Brain Sci. Aging Knowl. Environ., March 8, 2006; 2006(6): re1 - re1. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P.F. Rutten, N. M. Van der Kolk, S. Schafer, M. A.M.J. van Zandvoort, T. A. Bayer, H. W.M. Steinbusch, and C. Schmitz Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice Am. J. Pathol., July 1, 2005; 167(1): 161 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Cole, A. Grudzien, I. O. Manhart, B. L. Kelly, H. Oakley, and R. Vassar Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, {beta}-Secretase-cleaved Fragments, and Amyloid {beta}-Peptide via an Isoprenoid-dependent Mechanism J. Biol. Chem., May 13, 2005; 280(19): 18755 - 18770. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Langui, N. Girardot, K. H. El Hachimi, B. Allinquant, V. Blanchard, L. Pradier, and C. Duyckaerts Subcellular Topography of Neuronal A{beta} Peptide in APPxPS1 Transgenic Mice Am. J. Pathol., November 1, 2004; 165(5): 1465 - 1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Casas, N. Sergeant, J.-M. Itier, V. Blanchard, O. Wirths, N. van der Kolk, V. Vingtdeux, E. van de Steeg, G. Ret, T. Canton, et al. Massive CA1/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated A{beta}42 Accumulation in a Novel Alzheimer Transgenic Model Am. J. Pathol., October 1, 2004; 165(4): 1289 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Dickson Building a More Perfect Beast: APP Transgenic Mice with Neuronal Loss Am. J. Pathol., April 1, 2004; 164(4): 1143 - 1146. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |